ACHC stock icon

Acadia Healthcare

41.38 USD
+0.56
1.37%
Updated Nov 11, 11:39 AM EST
1 day
1.37%
5 days
-2.11%
1 month
-24.52%
3 months
-41.70%
6 months
-42.26%
Year to date
-47.12%
1 year
-43.19%
5 years
35.67%
10 years
-32.69%
 

About: Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Employees: 23,500

0
Funds holding %
of 6,759 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

126% more call options, than puts

Call options by funds: $25.1M | Put options by funds: $11.1M

17% more funds holding in top 10

Funds holding in top 10: 6 [Q1] → 7 (+1) [Q2]

2.39% more ownership

Funds ownership: 102.45% [Q1] → 104.84% (+2.39%) [Q2]

5% less funds holding

Funds holding: 317 [Q1] → 302 (-15) [Q2]

12% less capital invested

Capital invested by funds: $7.48B [Q1] → $6.57B (-$911M) [Q2]

21% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 130

25% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 59

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$76
84%
upside
Avg. target
$88
113%
upside
High target
$94
127%
upside

6 analyst ratings

positive
33%
neutral
67%
negative
0%
Cantor Fitzgerald
Sarah James
40% 1-year accuracy
57 / 141 met price target
118%upside
$90
Neutral
Reiterated
4 Oct 2024
Cantor Fitzgerald
Sarah James
40% 1-year accuracy
57 / 141 met price target
118%upside
$90
Neutral
Reiterated
1 Oct 2024
Barclays
Andrew Mok
53% 1-year accuracy
31 / 58 met price target
84%upside
$76
Overweight
Maintained
30 Sept 2024
RBC Capital
Ben Hendrix
51% 1-year accuracy
33 / 65 met price target
127%upside
$94
Outperform
Reiterated
20 Sept 2024
Cantor Fitzgerald
Sarah James
40% 1-year accuracy
57 / 141 met price target
118%upside
$90
Neutral
Reiterated
20 Aug 2024

Financial journalist opinion

Based on 248 articles about ACHC published over the past 30 days

Charts implemented using Lightweight Charts™